256 filings
8-K
ALNY
Alnylam Pharmaceuticals Inc
4 Mar 24
Departure of Directors or Certain Officers
4:33pm
8-K
ALNY
Alnylam Pharmaceuticals Inc
15 Feb 24
Results of Operations and Financial Condition
8:10am
8-K
ALNY
Alnylam Pharmaceuticals Inc
19 Jan 24
Departure of Directors or Certain Officers
4:31pm
8-K
ALNY
Alnylam Pharmaceuticals Inc
8 Jan 24
Alnylam Announces Preliminary* Fourth Quarter and Full Year 2023 Global Net Product Revenues and Provides Additional Updates
7:00am
8-K
ALNY
Alnylam Pharmaceuticals Inc
2 Nov 23
Results of Operations and Financial Condition
8:10am
8-K
j1f opq9i
10 Oct 23
Alnylam Announces Receipt of Complete Response Letter from U.S. FDA for Supplemental New Drug Application for Patisiran for the Treatment of the
7:30am
8-K
mma0sfhli5
28 Sep 23
Departure of Directors or Certain Officers
5:00pm
8-K
zfzpve4my fl5
3 Aug 23
Alnylam Pharmaceuticals Reports Second Quarter 2023 Financial Results and Highlights Recent Period Activity
8:10am
8-K
g6kfbp9jqvp
26 Jul 23
Entry into a Material Definitive Agreement
5:15pm
8-K
vovk3bh53gqovkj48
30 Jun 23
Alnylam Announces Date of Planned FDA Advisory Committee Meeting for ONPATTRO® (patisiran) for the Treatment of the Cardiomyopathy of ATTR
9:03am
8-K
arxo9
23 May 23
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
ay1ugjquo
4 May 23
Results of Operations and Financial Condition
8:10am
8-K
wdb2az0z82g3nfzkve
8 Mar 23
Departure of Directors or Certain Officers
4:30pm
8-K
5vtb5d
23 Feb 23
Results of Operations and Financial Condition
8:10am
8-K
mcfu6dhbottik
9 Jan 23
Alnylam Announces Preliminary* Fourth Quarter and Full Year 2022 Global Net Product Revenues and Provides Additional Updates
7:00am
8-K
zi9h7su
6 Jan 23
Alnylam Announces Updates to its Board of Directors
4:16pm
8-K
ubf5r4 kej5c
27 Oct 22
Results of Operations and Financial Condition
8:10am
8-K
j55nlicr 1k8
16 Sep 22
Entry into a Material Definitive Agreement
5:10pm
8-K
7mfi74 4gf5ud
13 Sep 22
Alnylam Announces Proposed Offering of $900 Million Convertible Senior Notes
4:05pm
8-K
uiw3iwhbe3tc
24 Aug 22
Departure of Directors or Certain Officers
4:16pm